Metabolic cardiology: an integrative strategy in the treatment of congestive heart failure.
Level 5 - mechanism / opinion, no new human data
Narrative commentary and mechanism-based reasoning without original clinical data
What was done
This communication paper presents the rationale for "metabolic cardiology" in the management of congestive heart failure and dilated cardiomyopathy. It describes the biochemical basis for using nutritional interventions—specifically D-ribose, L-carnitine, and coenzyme Q10—to preserve energy substrates and enhance adenosine triphosphate (ATP) production in the failing myocardium.
What was found
The abstract reports no empirical clinical data, trial results, or quantitative findings.
Why it matters
It introduces a theoretical framework focused on supporting myocardial bioenergetics alongside conventional heart failure therapies.
Limits
This is a narrative, theoretical paper without original clinical trial data, human subjects, control groups, or statistical outcomes.
Cited by
- context Administering a metabolic supplement cocktail including CoQ10, carnitine, creatine, ribose, alpha-lipoic acid, N-acetylcysteine, and B vitamins improves ejection fraction in heart failure patients.